雪榕生物
(300511)
| 流通市值：23.41亿 | | | 总市值：26.34亿 |
| 流通股本：5.70亿 | | | 总股本：6.41亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 128,389,489.19 | 176,473,068.8 | 297,508,656.19 | 161,452,486.54 |
| 应收票据及应收账款 | 44,116,092.22 | 43,718,246.49 | 46,084,391.38 | 43,768,360.92 |
| 其中：应收票据 | - | 2,150,000 | - | - |
| 应收账款 | 44,116,092.22 | 41,568,246.49 | 46,084,391.38 | 43,768,360.92 |
| 预付款项 | 17,399,514.58 | 12,718,583.07 | 15,126,982.08 | 11,439,944.52 |
| 其他应收款合计 | 6,200,524.11 | 5,252,614.71 | 5,783,757.59 | 8,598,631.03 |
| 存货 | 379,561,213.02 | 355,339,066.12 | 399,988,353.87 | 371,681,031.33 |
| 一年内到期的非流动资产 | 4,295,809.31 | 8,357,243.75 | 4,204,928.49 | 4,108,828.46 |
| 其他流动资产 | 7,696,854.51 | 4,811,267.01 | 5,562,561.17 | 4,991,345.3 |
| 流动资产合计 | 587,659,496.94 | 606,670,089.95 | 774,259,630.77 | 606,040,628.1 |
| 非流动资产: | | | | |
| 长期应收款 | 8,872,947.8 | 8,850,335.87 | 5,979,577.81 | 7,456,965.88 |
| 其他非流动金融资产 | 9,481,010.39 | 9,481,010.39 | 12,046,795.26 | 12,046,795.26 |
| 固定资产 | 2,466,237,269.06 | 2,500,775,909.87 | 2,559,353,053.9 | 2,633,028,695.1 |
| 在建工程 | 87,859,963.51 | 70,356,535.16 | 30,301,836.45 | 20,280,413.46 |
| 使用权资产 | 9,404,609.36 | 9,767,869.49 | 9,757,624.54 | 10,304,461.15 |
| 无形资产 | 290,568,282.28 | 293,122,360.37 | 296,191,781.04 | 299,430,594.73 |
| 长期待摊费用 | 10,420,697.23 | 10,705,226.64 | 5,643,690.39 | 6,141,879.09 |
| 其他非流动资产 | 25,690,202.05 | 16,804,696.84 | 15,225,215.49 | 6,633,900.43 |
| 非流动资产合计 | 2,908,534,981.68 | 2,919,863,944.63 | 2,934,499,574.88 | 2,995,323,705.1 |
| 资产总计 | 3,496,194,478.62 | 3,526,534,034.58 | 3,708,759,205.65 | 3,601,364,333.2 |
| 流动负债: | | | | |
| 短期借款 | 910,740,350.24 | 939,104,291.52 | 366,895,874.23 | 856,086,588.46 |
| 应付票据及应付账款 | 315,022,377.47 | 267,856,483.15 | 259,580,435.97 | 320,954,687.54 |
| 其中：应付票据 | 32,826,549.29 | 37,200,545.2 | 16,343,210.03 | 5,503,210.03 |
| 应付账款 | 282,195,828.18 | 230,655,937.95 | 243,237,225.94 | 315,451,477.51 |
| 合同负债 | 8,502,586.11 | 8,197,807.79 | 10,824,518.12 | 6,472,983.78 |
| 应付职工薪酬 | 55,164,162.36 | 50,037,284.9 | 44,744,895.03 | 49,117,546.05 |
| 应交税费 | 6,337,564.24 | 5,022,974.81 | 4,866,599.01 | 4,657,748.9 |
| 其他应付款合计 | 271,478,344.6 | 281,887,202.01 | 326,535,559.38 | 397,024,725.79 |
| 一年内到期的非流动负债 | 86,100,186.48 | 80,734,969.5 | 163,615,297.57 | 122,483,619.34 |
| 流动负债合计 | 1,653,345,571.5 | 1,632,841,013.68 | 1,177,063,179.31 | 1,756,797,899.86 |
| 非流动负债: | | | | |
| 长期借款 | 211,607,159.62 | 216,307,159.62 | 739,696,235.11 | 219,982,215 |
| 租赁负债 | 16,118,139.7 | 16,092,391.55 | 16,649,574.24 | 21,072,401.34 |
| 长期应付款 | 86,998,033.06 | 74,613,485.97 | 30,886,951.11 | 32,839,464.88 |
| 递延收益 | 52,121,597.07 | 54,261,610.72 | 56,401,624.38 | 57,185,559.59 |
| 非流动负债合计 | 366,844,929.45 | 361,274,647.86 | 843,634,384.84 | 331,079,640.81 |
| 负债合计 | 2,020,190,500.95 | 1,994,115,661.54 | 2,020,697,564.15 | 2,087,877,540.67 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 640,847,016 | 640,847,016 | 640,847,016 | 640,847,016 |
| 资本公积 | 1,327,838,928.47 | 1,321,256,998.75 | 1,314,139,612.15 | 1,314,061,399.11 |
| 其他综合收益 | -7,337,014.04 | -6,672,943.44 | -6,000,713.03 | -4,703,410.71 |
| 盈余公积 | 96,775,007.87 | 96,775,007.87 | 96,775,007.87 | 96,775,007.87 |
| 未分配利润 | -482,351,336.71 | -417,103,924.06 | -261,788,494.07 | -434,958,854.21 |
| 归属于母公司股东权益合计 | 1,575,772,601.59 | 1,635,102,155.12 | 1,783,972,428.92 | 1,612,021,158.06 |
| 少数股东权益 | -99,768,623.92 | -102,683,782.08 | -95,910,787.42 | -98,534,365.53 |
| 股东权益合计 | 1,476,003,977.67 | 1,532,418,373.04 | 1,688,061,641.5 | 1,513,486,792.53 |
| 负债和股东权益合计 | 3,496,194,478.62 | 3,526,534,034.58 | 3,708,759,205.65 | 3,601,364,333.2 |
| 公告日期 | 2026-10-27 | 2026-08-25 | 2026-04-28 | 2026-04-28 |
| 审计意见(境内) | | | | 标准无保留意见 |